Skip to content
  • Home
  • About Us
  • Apply
  • News & Articles
  • Contact Us
Menu
  • Home
  • About Us
  • Apply
  • News & Articles
  • Contact Us

February 2024

Biocentury: Singapore’s next challenge: turning momentum into sustainable growth

Leave a Comment / Articles / By 65LAB

Read about the key role of 65LAB in Singapore’s burgeoning ecosystem, as it seeks to advance academic projects through the steps towards company formation.

Evotec’s White Paper Series: From Academic Concept to Commercial Reality: How to Accelerate Translational Drug Discovery

Leave a Comment / Articles / By 65LAB

Discover more about the way-markers for a successful translational roadmap from the investor’s perspective Discover more from Evotec

Drug Discovery World Winter issue 2023/ 2024

Leave a Comment / Articles / By 65LAB

Read DDW’s insights into whether AI can deliver better immunotherapies for cancer, and predictions on what to expect from the sector in 2024 Read

Recent Posts

  • Singapore venture creation group 65LAB funds novel biologics project from National University of Singapore targeting lung diseases
  • 65LAB awards US$1.5 million to Duke-NUS platform to advance antifibrotic drug discovery
  • 65LAB and Duke-NUS award US$1.85 million to combat chronic inflammation
  • Biocentury: Singapore’s next challenge: turning momentum into sustainable growth
  • Evotec’s White Paper Series: From Academic Concept to Commercial Reality: How to Accelerate Translational Drug Discovery

Recent Comments

No comments to show.

Archives

  • May 2026
  • August 2025
  • July 2024
  • February 2024
  • December 2023

Categories

  • Articles
  • Press Release
  • Home
  • About Us
  • Apply
  • News & Articles
  • Contact Us
  • Home
  • About Us
  • Apply
  • News & Articles
  • Contact Us

79 Science Park Drive
Cintech IV, #04-05
Singapore 118264

2023 © Copyright of 65LAB